BioSpace News Archive

Armis Biopharma Inc. announced the launch of a new surface disinfectant called ArmiClenz™.

Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., announced today a research collaboration with the Harvard Chan Microbiome in Public Health Center (HCMPH Center), a group at Harvard T.H. Chan School

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration has posted information on its website regarding the revised schedule for completion of the ARISE-3 dry eye clinical trial, http://www.regenerx.com/2020-06-02-June-2-2020-Advi

ReddyPort, a medical technology company focused on solutions that enable better care experiences for patients on non-invasive ventilation (NIV), announced today that it has received Conformité

Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, has obtained the occupancy permits for its newly built R&D Center for Innovative Drugs, meaning it has completed the construction of the facility.

The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bactiguard launched Hydrocyn

Medtronic Canada ULC, a subsidiary of Medtronic plc – one of the world’s largest medical technology, services, and solutions companies – announced that it has been named on the 2020 list of Best Workplaces for mental wellness.

Contemporary Pediatrics®, a trusted multimedia platform featuring clinical articles, case studies and practice management tips for pediatricians and other pediatric health care providers, recently released the webinar “Multisystem Inflammatory Syndrome in Children: A New Wrinkle in COVID-19 infection.”

Nano-X Imaging Ltd. (“Nanox” or the “Company”), a medical imaging technology company, today announced that Ran Poliakine, Founder and Chief Executive Officer, will present a company overview at the Jefferies Virtual Global Healthcare Conference on Thursday, June 4, 2020 at 2:00 pm Eastern time.

Bigfoot Biomedical, Inc. announced today that the company has raised a total of $55 million to close its Series C equity financing